Suppr超能文献

多结节性肝细胞癌微血管侵犯的术前预测因子。

Preoperative predictors of microvascular invasion in multinodular hepatocellular carcinoma.

机构信息

Department of Hepatobiliary Surgery, PLA Navy General Hospital, No. 6 Fucheng Road, Beijing 100048, China.

出版信息

Eur J Surg Oncol. 2013 Aug;39(8):858-64. doi: 10.1016/j.ejso.2013.04.003. Epub 2013 May 11.

Abstract

BACKGROUND

The preoperative predictors of microvascular invasion (MVI) in multinodular hepatocellular carcinoma (HCC) are currently unclear.

METHODS

We retrospectively analyzed 266 patients who underwent potentially curative resection of multinodular HCC. MVI was diagnosed on pathological examination in 64 patients. Preoperative risk factors for MVI were identified and survival curves were analyzed.

RESULTS

Patients with MVI had significantly lower overall and recurrence-free survival rates than those without MVI (overall survival, 1 year: 86% vs. 71%, 3 years: 58% vs. 16%; recurrence-free survival, 1 year: 69% vs. 12%; 3 years: 48% vs. 12%; both P < 0.001). Multivariate analysis showed that serum alpha-fetoprotein (AFP) level >400 μg/L (odds ratio [OR] = 3.732, P = 0.016), serum gamma-glutamyltransferase (GGT) level >130 U/L (OR = 19.779, P < 0.001), total tumor diameter >8 cm (OR = 5.545, P = 0.010), and tumor number >3 (OR = 11.566, P = 0.007) were independent predictors of MVI. A scoring system was constructed, and the MVI rate was significantly higher in patients with a score of ≥3 than those with a score of <3 (64.1% vs. 10.9%, P < 0.001). Overall and recurrence-free survival rates were significantly lower in patients with a score of ≥3 (both P < 0.001).

CONCLUSIONS

Serum AFP level >400 μg/L, serum GGT level >130 U/L, total tumor diameter >8 cm, and tumor number >3 were preoperative predictors of MVI in patients with multinodular HCC. In patients with a high risk of MVI and well-preserved liver function, anatomic resection may be worth considering.

摘要

背景

目前尚不清楚多结节性肝细胞癌(HCC)中微血管侵犯(MVI)的术前预测因素。

方法

我们回顾性分析了 266 例接受多结节性 HCC 根治性切除术的患者。64 例患者的 MVI 经病理检查诊断。确定 MVI 的术前危险因素,并分析生存曲线。

结果

MVI 患者的总生存率和无复发生存率明显低于无 MVI 患者(总生存率:1 年为 86%比 71%,3 年为 58%比 16%;无复发生存率:1 年为 69%比 12%,3 年为 48%比 12%;均 P<0.001)。多变量分析显示,血清甲胎蛋白(AFP)水平>400μg/L(比值比[OR] = 3.732,P = 0.016)、血清γ-谷氨酰转肽酶(GGT)水平>130 U/L(OR = 19.779,P<0.001)、肿瘤总直径>8cm(OR = 5.545,P = 0.010)和肿瘤数目>3 个(OR = 11.566,P = 0.007)是 MVI 的独立预测因素。构建了评分系统,评分≥3 分的患者 MVI 发生率明显高于评分<3 分的患者(64.1%比 10.9%,P<0.001)。评分≥3 分的患者总生存率和无复发生存率明显较低(均 P<0.001)。

结论

血清 AFP 水平>400μg/L、血清 GGT 水平>130 U/L、肿瘤总直径>8cm、肿瘤数目>3 个是多结节性 HCC 患者 MVI 的术前预测因素。对于 MVI 风险高且肝功能良好的患者,解剖性切除术可能值得考虑。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验